e-learning
resources
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Spacer devices for inhaled therapy: why use them, and how?
Walter Vincken, Mark L. Levy, Jane Scullion, Omar S. Usmani, P.N. Richard Dekhuijzen, Chris J. Corrigan
Source:
ERJ Open Res, 4 (2) 00065-2018; 10.1183/23120541.00065-2018
Journal Issue:
April
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Walter Vincken, Mark L. Levy, Jane Scullion, Omar S. Usmani, P.N. Richard Dekhuijzen, Chris J. Corrigan. Spacer devices for inhaled therapy: why use them, and how?. ERJ Open Res, 4 (2) 00065-2018; 10.1183/23120541.00065-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
How to choose and use an inhaler device?
Source: Virtual Congress 2021 – Updates on inhalers for COPD and asthma
Year: 2021
Inhaled medication: which device for which patient?
Source: Eur Respir Monogr 2015; 69: 213-223
Year: 2015
The issues and the controversies: are we really ready for on-demand use of ICS?
Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use?
Year: 2013
Inhaled therapies: can they breathe new life into asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019
How patients use inhalers - what are the critical errors?
Source: International Congress 2017 – Advances in Inhaler technology - intuitive design and better drug delivery
Year: 2017
How can we improve patient use of inhaler devices in COPD?
Source: Annual Congress 2011 - Drug delivery and pharmacokinetics II
Year: 2011
Optimising bronchodilator therapy in COPD: Who, why and when?
Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care
Year: 2019
Inhaled antibiotics: a new tool?
Source: Annual Congress 2009 - Antibiotics and the lung
Year: 2009
The sustainability agenda and inhaled therapy: what do patients want?
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021
Is there a problem with inhaled corticosteroid use in COPD?
Source: Virtual Congress 2020 – Airway diseases
Year: 2020
Investigating the steroids and long-acting β2-agonists combination: why do we need more?
Source: Eur Respir J 2004; 23: 501-502
Year: 2004
Cough assist devices: what, when and how?
Source: International Congress 2019 – Sleep and neuromuscular diseases: assessment and management of respiratory problems
Year: 2019
Foundation doctor knowledge of inhaled devices - Are the old better than the new?
Source: International Congress 2016 – Abstracts in medical education, the web and the internet
Year: 2016
Factors affecting choice of inhalers: who is choosing for whom?
Source: Annual Congress 2007 - Primary care: delivering the goods: "inhaled therapies"
Year: 2007
Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers
Source: Eur Respir J, 55 (2) 2000048; 10.1183/13993003.00048-2020
Year: 2020
Minimising the environmental impact of inhaled therapies: problems with policy on low carbon inhalers
Source: Eur Respir J, 55 (5) 2001122; 10.1183/13993003.01122-2020
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept